NIDA Legislative Resources

• NIDA Legislative Chronology
• NIDA Directors Report - Complete
  
  • Congressional Affairs Overview
    • 2008: February, May, September
    • 2007: February, May, September
    • 2006: February, May, September
    • 2005: February, May, September
    • 2004: February, May, September
    • 2003: February, May, September
    • 2002: February, May, September
    • 2001: February, May, September
    • 2000: February, May, September
    • 1999: February, May, September
    • 1998: February, May, September
    • 1997: February, May, September
    • 1996: February, May, September
    • 1995: February, May, September
  
  
• Budget Information (Congressional Justification)
  • Fiscal Year 2009, 2008, 2007, 2006, 2005,2004, 2003 , 2002 , 2001
    
    
• Drug Abuse and Addiction Research - The Sixth Triennial Report to Congress
  
  
• Marijuana Research and Dissemination Update - March 2004 [PDF format - 248 Kb]
  • Summary in Powerpoint format - [Powerpoint, 3.4 MB]


• Testimony to Congress

  Index for 2008

  • "Scientific Research on Prescription Drug Abuse" - Before the Subcommittee on Crime and Drugs, Committee on the Judiciary and the Caucus on International Narcotics Control United States Senate - Statement of Nora D. Volkow, M.D. (3/12/08)
  • "Fiscal Year 2009 Budget Request Before the House Subcommittee on Labor-HHS-Education Appropriations - Statement of Nora D. Volkow, M.D. (3/5/08)
  • "Scientific Research on the Scope, Pharmacology, and Health Consequences of Cocaine Abuse and Addiction" - Testimony before the Subcommittee on Crime and Drugs, Committee on the Judiciary, United States Senate - Statement of Nora D. Volkow, M.D. (2/12/08)

  Index for 2007

  • "Mind, Brain, and Behavior" - Fiscal Year 2008 Budget Request - Testimony before the Senate Subcommittee on Labor-HHS-Education Appropriations - Statement of Nora D. Volkow, M.D. (3/26/07)
  • Fiscal Year 2008 Budget Request - Testimony before the House Subcommittee on Labor-HHS-Education Appropriations - Statement of Nora D. Volkow, M.D. (3/1/07)

  Index for 2006

  • Testimony at the United States Sentencing Commission Public Hearing on the scope, pharmacology and health consequences of cocaine abuse and addiction - Statement of Nora D. Volkow, M.D. (11/14/06)
  • Efforts of the National Institute on Drug Abuse to Prevent and Treat Prescription Drug Abuse - Testimony Before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources Committee on Government Reform, United States House of Representatives - Statement of Nora D. Volkow, M.D. (7/26/06)
  • Availability and Effectiveness of Programs to Treat Methamphetamine Abuse - Testimony before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources - Committee on Government Reform - United States House of Representatives - Statement of Nora D. Volkow, M.D. (6/28/06)
  • Fiscal Year 2007 Budget Request - Testimony before the House Subcommittee on Labor-HHS-Education Appropriations - Statement of Nora D. Volkow, M.D. (3/16/06)
  • An Examination of Drug Treatment Programs Needed to Ensure Successful Re-entry - Testimony before the Subcommittee on Crime, Terrorism, and Homeland Security, Committee on the Judiciary - Statement of Nora D. Volkow, M.D. (2/8/06)

  Index for 2005

  • Medications Development Research for Treatment of Amphetamine and Methamphetamine Addiction - Report to Congress (8/05)
  • Substance Abuse and Mental Health Research and Services - Testimony before the House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies - Committee on Appropriations - Statement of Nora D. Volkow, M.D. (4/27/05)
  • Methamphetamine Abuse - Testimony before the Senate Subcommittee on Labor, Health and Human Services, Education, and Related Agencies - Committee on Appropriations - Statement of Nora D. Volkow, M.D. (4/21/05)
  • Fiscal Year 2006 Budget Request to Senate Subcommittee - Statement of Nora D. Volkow, M.D. (4/6/05)
  • Fiscal Year 2006 Budget Request to House Subcommittee - Statement of Nora D. Volkow, M.D. (3/9/05)
  • Consequences of the Abuse of Anabolic Steroids - Before the Committee on Government Reform - Statement of Nora D. Volkow, M.D. (3/17/05)

  Index for 2004

  • Fiscal Year 2005 Budget Request to House Subcommittee - Statement of Nora D. Volkow, M.D. (4/29/04)
  • Marijuana and Medicine: The Need for a Science-Based Approach - Statement of Nora D. Volkow, M.D. (4/1/04)
  • Fiscal Year 2005 Budget Request to Senate Subcommittee - Statement of Nora D. Volkow, M.D. (4/1/04)
  • Measuring The Effectiveness of Drug Addiction Treatment - Statement of Nora D. Volkow, M.D. (3/30/04)

  Index for 2003

  • Fiscal Year 2004 Budget Request - Statement of Glen R. Hanson, Ph.D., D.D.S. (4/8/03)

  Index for 2002

  • Research on MDMA - Testimony Before the Subcommittee on Criminal Justice, Drug Policy and Human Resources - Statement of Glen R. Hanson, Ph.D., D.D.S. (9/19/02)
  • Oversight Hearing on the Office of National Drug Control Policy's National Youth Anti-Drug Media Campaign - Statement of Wilson M. Compton, M.D, M.P.E. (6/20/02)
  • Fiscal Year 2003 Budget Request - Statement of Glen R. Hanson, Ph.D., D.D.S. (3/13/02)
  • "OxyContin: Balancing Risks and Benefits" - Hearing before the Health, Education, Labor, and Pensions Committee United States Senate (2/12/02)

  Index for 2001

  • "Looking the Other Way: Rave Promoters and Club Drugs" - Hearing before the Senate Caucus on International Narcotics Control (12/4/01)
  • Evaluation of the Office of National Drug Control Policy's (ONDCP's) National Youth Anti-Drug Media Campaign - Hearing Before the House Government Reform Subcommittee on Criminal Justice, Drug Policy and Human Resources (8/1/01)
  • Ecstasy Abuse and Control - Hearing Before the Senate Subcommittee on Governmental Affairs (7/30/01)
  • Continuing Concern over Imported Pharmaceuticals - Hearing Before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives (6/7/01)
  • Fiscal Year 2002 Budget Request - Statement of Alan I. Leshner, Ph.D. (5/16/01)
  • "Treatment, Education, and Prevention - Adding to the Arsenal in the War on Drugs" - Hearing before the Senate Committee on the Judiciary (3/14/01).

  Index for 2000

  • Formal Statement for the Record on Club Drugs (MDMA, Ecstasy) by Alan I. Leshner, Ph.D. to the "U.S. Senate Caucus on International Narcotics Control"
  • Statement of Alan I. Leshner, Ph.D. at the "Oversight Hearing on Programs of the Substance Abuse and Mental Health Services Administration (SAMHSA) and SAMHSA coordination with the National Institute on Drug Abuse"
  • Statement of Alan I. Leshner, Ph.D. on Fiscal Year 2001 Budget Request

  Index for 1999

  • Statement of Alan I. Leshner, Ph.D. on Heroin Abuse and Addiction
  • Statement of Alan I. Leshner, Ph.D. on The Drug Addiction Treatment Act of 1999
  • Statement of Alan I. Leshner, Ph.D. on "Drug Legalization"
  • Statement of Timothy P. Condon, Ph.D. on Science-Based Approaches to Preventing and Treating Heroin Abuse and Addiction
  • Statement of Alan I. Leshner, Ph.D. at the Hearing on National Youth Anti-Drug Media
  • Statement of Richard A. Millstein
  • Statement by Stephen Zukin, M.D.
  • Statement of Alan I. Leshner, Ph.D. on Fiscal Year 2000 Budget Request

  Index for 1998

  • Statement by James Cooper, M.D. on Methadone and the Treatment of Heroin Addiction
  • Statement of Alan I. Leshner, Ph.D. on Fiscal Year 1999 Budget Request
  • Statement of Alan I. Leshner, Ph.D. on Nicotine

  Index for 1997

  • Formal statement on Children Health Issues
  • Formal statement

Other Legislative Links

• THOMAS Home Page
• House
• Senate
• Office of Legislative and Policy Analysis, National Institutes of Health
• National Cancer Institute
• National Human Genome Research Institute

Contact

National Institute on Drug Abuse
Office of Science Policy and Communications, Science Policy Branch
6001 Executive Boulevard, Room 5230, MSC 9591
Bethesda, Maryland 20892-9591
Phone : (301) 443-6071; Fax (301) 443-9731
e-mail: information@nida.nih.gov